Cannabis Stocks Ratings

Cannabis Reports Highlight $339M And $297.6M Revenue Insights In Curaleaf And Trulieve's Q1 2024 Financials

How Big Caps Rewrite Valuation Rules In Cannabis: Cash Puzzle For Companies Above And Below $500M

Marijuana Investors Bet Big On Long-Term Growth Over Short-Term Earnings As Market Value Rises By 39%

How Big Caps Rewrite Valuation Rules In Cannabis: Cash Puzzle For Companies Above And Below $500M

Marijuana Investors Bet Big On Long-Term Growth Over Short-Term Earnings As Market Value Rises By 39%

NASDAQ-Listed Marijuana Stocks, Tilray, Canopy, Aurora Rally: What's Behind The Surge?

Florida's $6B Cannabis Market Anticipates 400% Growth Following Court Decision Allowing Nov. Legalization Ballot

NASDAQ-Listed Marijuana Stocks, Tilray, Canopy, Aurora Rally: What's Behind The Surge?

Florida's $6B Cannabis Market Anticipates 400% Growth Following Court Decision Allowing Nov. Legalization Ballot

Green Thumb's Edge Over S&P 500 & ETFs: Cannabis Investor Confidence Propels Expansion Into Key States

Fast Track Recap: Colorado & Michigan Weed Sales Decline, Virginia Eyes Legal Market, Stock Winners & Losers

Cannabis Stocks Ratings Recent News

TILT's Bull vs. Bear Case: EBITDA Potential In Its Cannabis Business - Analyst Insights

Zuanic & Associates (Z&A), an equity research firm has initiated coverage of TILT Holdings (OTC: TLLTF), a micro-cap stock with a $12 million market cap, with an Overweight rating.

BofA Lowers Price Target & Rating On Canopy Despite Its Strong Cash Position And U.S. Entry Plan...Why?

Year-to-date, Canopy Growth (NASDAQ: CGC) stock lost 68.45%, compared to AdvisorShares Pure Cannabis ETF (ARCA: YOLO) that went down 33.94%, and SPDR S&P 500 (ARCA: SPY) gaining 21.83%.